Cite
Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.
MLA
Zanin-Zhorov, Alexandra, et al. “Selective Oral ROCK2 Inhibitor Down-Regulates IL-21 and IL-17 Secretion in Human T Cells via STAT3-Dependent Mechanism.” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 47, Nov. 2014, pp. 16814–19. EBSCOhost, https://doi.org/10.1073/pnas.1414189111.
APA
Zanin-Zhorov, A., Weiss, J. M., Nyuydzefe, M. S., Wei Chen, Scher, J. U., Rigen Mo, Depoil, D., Rao, N., Ben Liu, Jianlu Wei, Lucas, S., Koslow, M., Roche, M., Schueller, O., Weiss, S., Poyurovsky, M. V., Tonra, J., Hippen, K. L., Dustin, M. L., & Blazar, B. R. (2014). Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proceedings of the National Academy of Sciences of the United States of America, 111(47), 16814–16819. https://doi.org/10.1073/pnas.1414189111
Chicago
Zanin-Zhorov, Alexandra, Jonathan M. Weiss, Melanie S. Nyuydzefe, Wei Chen, Jose U. Scher, Rigen Mo, David Depoil, et al. 2014. “Selective Oral ROCK2 Inhibitor Down-Regulates IL-21 and IL-17 Secretion in Human T Cells via STAT3-Dependent Mechanism.” Proceedings of the National Academy of Sciences of the United States of America 111 (47): 16814–19. doi:10.1073/pnas.1414189111.